High Court's Hikma Decision Reshapes 'Skinny Label' Suits
By Paul Ainsworth, William Milliken and Harrison Adams · June 9, 2026, 5:38 PM EDT
On June 4, the U.S. Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., marking a significant victory for generic drug manufacturers....
To view the full article, register now.